Evaluation of maternal and fetal Doppler parameters in women undergoing a 50-g oral glucose challenge test: a cross-sectional observational study
Irish Journal of Medical Science (1971 -) · 2025
DOI: 10.1007/s11845-025-04053-9 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Irish Journal of Medical Science (1971 -), 2025. Verfasst von Canan Satır Özel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Medeniyet University, 34722, Istanbul, Turkey. drcanansatirozel@gmail.com. Hauptthemen laut MEDLINE: Ultrasonography, Prenatal, Diabetes, Gestational, Fetus. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Glucose challenge tests (GCT) are routinely used to screen for gestational diabetes mellitus (GDM), yet their acute effects on maternal and fetal hemodynamics remain unclear. Understanding these physiological responses is important in the context of increasing patient concern regarding the safety of such tests. AIM: To investigate the acute effects of 50 g GCT on maternal and fetal Doppler ultrasound parameters in low-risk, healthy pregnant women. METHODS: Forty-nine participants between 24 and 28 gestational weeks were included in this prospective study. Doppler ultrasound examinations were performed to assess fetal and placental circulation. The Pulsatility Index (PI), Resistance Index (RI), and PI Z-scores were analyzed for the umbilical artery (UA), uterine artery (UtA), and middle cerebral artery (MCA). The cerebroplacental ratio (CPR) and its Z-score were also analyzed. All measurements were performed at the 0th and 1st hours of the GCT. RESULTS: There were no significant changes in fetal MCA-PI, UA-PI, or CPR Z-scores following glucose intake (p > 0.05 for all). However, there was a significant increase in maternal uterine artery PI and RI values at the first hour of the GCT (PI, p = 0.031; RI, p = 0.002). These findings suggest a transient increase in uteroplacental vascular resistance in response to acute hyperglycemia. CONCLUSION: Acute maternal hyperglycemia from the 50-g GCT may alter uterine artery blood flow without significantly affecting fetal Doppler indices. These subtle changes require further investigation, particularly in high-risk pregnancies or metabolic disorders, to inform clinical decisions and patient counseling regarding GCT use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Medeniyet University, 34722, Istanbul, Turkey. drcanansatirozel@gmail.com.
- Division of Perinatology, Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
- Department of Public Health, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Medeniyet University, 34722, Istanbul, Turkey.
Zitieren
APA
Satır Özel, C., Ayaz Bilir, R., Çakır, M., Demirçivi, E., Yardımcı, O. D., & Turgut, A. (2025). Evaluation of maternal and fetal Doppler parameters in women undergoing a 50-g oral glucose challenge test: a cross-sectional observational study. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-025-04053-9
Vancouver
Satır Özel C, Ayaz Bilir R, Çakır M, Demirçivi E, Yardımcı OD, Turgut A. Evaluation of maternal and fetal Doppler parameters in women undergoing a 50-g oral glucose challenge test: a cross-sectional observational study. Irish Journal of Medical Science (1971 -). 2025. doi:10.1007/s11845-025-04053-9
BibTeX
@article{Satrzel2025,
author = {Satır Özel, Canan and Ayaz Bilir, Reyhan and Çakır, Mustafa and Demirçivi, Ergül and Yardımcı, Oğuz Devrim and Turgut, Abdulkadir},
title = {Evaluation of maternal and fetal Doppler parameters in women undergoing a 50-g oral glucose challenge test: a cross-sectional observational study},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2025},
doi = {10.1007/s11845-025-04053-9}
}
EUVIMED